These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 6218992)
1. Regulation of myocardial function in the normal and diseased heart. Modification by inotropic drugs. Katz AM; Smith VE Eur Heart J; 1982 Dec; 3 Suppl D():11-8. PubMed ID: 6218992 [No Abstract] [Full Text] [Related]
2. [Functional morphology of the myocardium in normal state and in cardiac insufficiency]. Krymskiĭ LD; Nestaĭko GV Sov Med; 1975 Oct; (10):51-7. PubMed ID: 128836 [No Abstract] [Full Text] [Related]
3. [Calcium sensitizers--a new group of drugs that increase myocardium contractility]. Laine M; Lehtonen L; Nieminen MS Duodecim; 2000; 116(20):2181-3. PubMed ID: 12017622 [No Abstract] [Full Text] [Related]
4. Classification of positive inotropic actions based on electrophysiologic characteristics: where should calcium sensitizers be placed? Varro A; Papp JG J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S32-44. PubMed ID: 8907129 [TBL] [Abstract][Full Text] [Related]
5. Hemodynamic effects of calcium-sensitizing agents. Vegh A; Papp JG; Udvary E; Kaszala K J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S20-31. PubMed ID: 8907128 [TBL] [Abstract][Full Text] [Related]
6. Effects of AR-L 115 BS on the electrophysiological and contractile properties of sheep cardiac fibres. Achenbach C; Hauswirth O; Roskothen R; Ziskoven R Arzneimittelforschung; 1981; 31(1a):171-6. PubMed ID: 7195214 [No Abstract] [Full Text] [Related]
7. Calcium sensitizers in chronic heart failure: inotropic interventions-reservation to preservation. Teramura S; Yamakado T Cardiologia; 1998 Apr; 43(4):375-85. PubMed ID: 9659795 [TBL] [Abstract][Full Text] [Related]
8. Regulation of myocardial function in health and critical illness. Williams GA; Ayres SM Crit Care Clin; 1985 Nov; 1(3):435-51. PubMed ID: 3916788 [TBL] [Abstract][Full Text] [Related]
10. Exercise training and cellular adaptations of normal and diseased hearts. Moore RL; Palmer BM Exerc Sport Sci Rev; 1999; 27():285-315. PubMed ID: 10791020 [No Abstract] [Full Text] [Related]
12. The effects of levosimendan on myocardial function in ropivacaine toxicity in isolated guinea pig heart preparations. Stehr SN; Christ T; Rasche B; Rasche S; Wettwer E; Deussen A; Ravens U; Koch T; Hübler M Anesth Analg; 2007 Sep; 105(3):641-7. PubMed ID: 17717217 [TBL] [Abstract][Full Text] [Related]
13. The failing human heart. Alpert NR; Mulieri LA; Warshaw D Cardiovasc Res; 2002 Apr; 54(1):1-10. PubMed ID: 12062354 [No Abstract] [Full Text] [Related]
14. Different preconditioning stimuli invoke disparate electromechanical and energetic responses to global ischemia in rat hearts. Rehring TF; Bender PR; Cairns CB; Joo K; Friese RS; Shapiro JI; Cleveland JC; Banerjee A Can J Physiol Pharmacol; 1997 Apr; 75(4):335-42. PubMed ID: 9196860 [TBL] [Abstract][Full Text] [Related]
15. Excitation-contraction-relaxation coupling in the normal and failing heart. Balke CW; Gold MR Heart Dis Stroke; 1993; 2(2):150-5. PubMed ID: 8149102 [No Abstract] [Full Text] [Related]
16. Adenosine triphosphate alters the selenite-induced contracture and negative inotropic effect on cardiac muscle contractions. Ugur M; Turan B Biol Trace Elem Res; 2001 Mar; 79(3):235-45. PubMed ID: 11354348 [TBL] [Abstract][Full Text] [Related]
17. Elevated levels of endogenous adenosine alter metabolism and enhance reduction in contractile function during low-flow ischemia: associated changes in expression of Ca(2+)-ATPase and phospholamban. Sommerschild HT; Lunde PK; Deindl E; Jynge P; Ilebekk A; Kirkebøen KA J Mol Cell Cardiol; 1999 Oct; 31(10):1897-911. PubMed ID: 10525427 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of crossbridge function in the normal human heart by hypoxic endothelial superfusate. Zacharzowsky UB; Shah AM; Haase H; Morano I Biochem Biophys Res Commun; 1999 Aug; 262(1):64-7. PubMed ID: 10448069 [TBL] [Abstract][Full Text] [Related]
19. The response of the calcium dependent myocardial contractility to the new cardiotonic agent sulmazole. Achenbach C; Ziskoven R; Wiemer J; Hauswirth O Arzneimittelforschung; 1984; 34(11):1498-506. PubMed ID: 6543125 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms of contraction of the normal and failing heart. Braunwald E; Ross J; Sonnenblick EH N Engl J Med; 1967 Oct; 277(15):794-800 contd. PubMed ID: 4227704 [No Abstract] [Full Text] [Related] [Next] [New Search]